[When and why should anti-GAD antibodies by looked for in the non-insulin-dependent diabetic patient?].
Atlan-Gepner
C
C
Service de Nutrition, Maladies Métaboliques et Endocrinologie, Hôpital Sainte Marguerite, Marseille.
Vialettes
B
B
D001323:Autoantibodies / Q000097:blood*; D003924:Diabetes Mellitus, Type 2 / Q000145:classification / Q000453:epidemiology / Q000276:immunology*; D005602:France / Q000453:epidemiology; D005968:Glutamate Decarboxylase / Q000276:immunology*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D015994:Incidence; D007328:Insulin / Q000627:therapeutic use
D001323:Autoantibodies; D007004:Hypoglycemic Agents; D007328:Insulin; D005968:Glutamate Decarboxylase
Quand et pourquoi rechercher les anticorps anti-GAD chez un diabétique non insulino-dépendant?